Synbias Co-Owns Cancer Drug IP, Can't Be Sued, Judge Rules
In an unusual case that required an interpretation of Ukrainian patent law to determine ownership of U.S. patents, a California federal judge has ruled that Synbias Pharma cannot be sued by...To view the full article, register now.
Already a subscriber? Click here to view full article